- Home
- FGEN vs DRIO Comparison
FGEN vs DRIO Comparison
Compare FGEN & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- DRIO
- Stock Information
- Founded
- FGEN 1993
- DRIO 2011
- Country
- FGEN United States
- DRIO United States
- Employees
- FGEN N/A
- DRIO N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- DRIO Medical/Dental Instruments
- Sector
- FGEN Health Care
- DRIO Health Care
- Exchange
- FGEN Nasdaq
- DRIO Nasdaq
- Market Cap
- FGEN 33.5M
- DRIO 30.5M
- IPO Year
- FGEN 2014
- DRIO N/A
- Fundamental
- Price
- FGEN $7.45
- DRIO $0.65
- Analyst Decision
- FGEN Strong Buy
- DRIO Strong Buy
- Analyst Count
- FGEN 1
- DRIO 2
- Target Price
- FGEN $250.00
- DRIO $2.50
- AVG Volume (30 Days)
- FGEN 48.5K
- DRIO 139.0K
- Earning Date
- FGEN 08-05-2025
- DRIO 08-07-2025
- Dividend Yield
- FGEN N/A
- DRIO N/A
- EPS Growth
- FGEN N/A
- DRIO N/A
- EPS
- FGEN N/A
- DRIO N/A
- Revenue
- FGEN $6,996,000.00
- DRIO $28,034,000.00
- Revenue This Year
- FGEN N/A
- DRIO $20.85
- Revenue Next Year
- FGEN N/A
- DRIO $17.09
- P/E Ratio
- FGEN N/A
- DRIO N/A
- Revenue Growth
- FGEN N/A
- DRIO 47.20
- 52 Week Low
- FGEN $4.50
- DRIO $0.50
- 52 Week High
- FGEN $33.49
- DRIO $1.55
- Technical
- Relative Strength Index (RSI)
- FGEN 55.79
- DRIO 37.33
- Support Level
- FGEN $7.31
- DRIO $0.65
- Resistance Level
- FGEN $7.82
- DRIO $0.74
- Average True Range (ATR)
- FGEN 0.59
- DRIO 0.04
- MACD
- FGEN 0.10
- DRIO -0.00
- Stochastic Oscillator
- FGEN 69.35
- DRIO 1.33
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.